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Covid 19 Oximetry@Home services have been commissioned nationally. This allows higher risk 
patients with mild Covid 19 symptoms to remain at home, being supplied with a Pulse Oximeter to 
measure their oxygen saturation (SpO2) two to three times daily for two weeks. Patients record their 
readings manually or electronically which are monitored by a clinical team. Clinical decisions, using 
an algorithm, are based on SpO2 readings in a narrow range with 1-2 point changes potentially 
affecting care. In this article we discuss the problem that multiple factors affect SpO2 readings, and 
that some ‘normal’ individuals will have ‘low normal’ scores at the threshold of clinical management, 
without any known respiratory problem. We discuss the potential magnitude of this problem based 
on the associated literature and consider how this will impact on the use of the Oximetry@home 
services, potentially partially confounding their purpose; to reduce face to face medical care. 
Background 
There are a number of advantages in managing less serious cases of COVID 19 in the community, 
though this limits the use of medical devices such as thermometers, stethoscopes and pulse 
oximeters during assessment. With the usefulness of patient performed home based pulse oximetry 
in both preventing unnecessary emergency department attendance (Torjesen, 2020) and in early 
identification of silent hypoxia however, NHS England has recommended national commissioning of 
‘Oximetry@Home’ services (NHSE1, 2020) where patients with mild Covid 19 symptoms but at higher 
risk of deterioration can be provided with a Pulse Oximeter for 14 days in order to self-monitor their 
oxygen saturation (SpO2) 2-3 times a day. 
 Patients referred to Oximetry@Home services are usually directed to use an App or a paper diary to 
record their observations. The App either provides an automated response/recommendation, or 
data is monitored by a clinician who can contact the patient if necessary, though usually only during 
normal working hours. Patients are given instructions on interpreting their results so they can act 
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independently if they need to, such as seeking urgent care. Those aged over 65 and/or with multiple 
comorbidities defining them as extremely vulnerable are being targeted by the pathway due to a 
higher risk of deterioration (NHSE1, 2020). 
The assessment of patients within Oximetry@Home services starts with their oxygen saturation as 
measured by a Pulse Oximeter, SpO2, followed by consideration of other signs and symptoms. A Red, 
Amber, Green (RAG) rating is used and patients are classified as Red if their SpO2 is 92% or less, 
Amber if their SpO2 is 93% or 94%, and Green if their SpO2 is 95% or greater. Usually only Green 
patients are eligible for Oximetry@Home (NHSE2, 2020). Various non-disease related factors 
influence SpO2 scores however and these may not be accounted for in the pathway. In this article we 
discuss the impact various factors affecting SpO2 may have on the movement of patients in and out 
of Oximetry@Home services that may partially confound their purpose : to ease the pressure on 
face to face medical services. 
The Variability of Oxygen Saturation Measurements 
The accepted range of ‘normal’ for oxygen saturation in the blood as measured by a pulse-oximeter 
(SpO2) is 95-99%. This statement is so ubiquitous that medical articles rarely reference it, though 
documents such as the World Health Organisation Pulse Oximetry Training Manual exist (WHO, 
2011). When searching for normative data regarding SpO2 in a non-medical population, little 
information can be found. In a study of 791 individuals aged 65 and over (Rodríguez-Molinero et al, 
2013) the mean 5th centile SpO2 score was 92% after accounting for variables such as COPD, 
indicating that 5% of the measured population had a significantly low score without any known 
medical explanation. In another study of 458 individuals aged between 40 and 79 (Enright & Sherrill, 
1998) the range of oxygen saturation before a 6-minute walk test was 92-98% at the 5th centile and 
93-99% at the 95th centile. Neither study documented in detail the procedure used to measure SpO2.  
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A population study of 5152 individuals in Norway (Vold et al, 2015) found that 11.5% had a low, or 
low end of normal, SpO2 of less than or equal to 95%. In this study only a minority of the individuals 
with a low SpO2 were reported to have asthma (18%) or COPD (13%), whereas a significant majority 
had a BMI over 25 (77%), and a large proportion were aged 70 or over (46%). In the UK, 24.4% of 
cases tested for Covid 19 between May and August 2020 were aged 60 or over and 15% were aged 
70 or over [8] (Dept Health and Social Care, 2020). Although the Norwegian study suggests 11.5% of 
any population may have a low SpO2, most of these cases having no known respiratory diagnosis, the 
literature suggests there may be “missing millions” with undiagnosed COPD (Bakerly & Cardwell, 
2016) and a potentially high rate of undiagnosed Obesity Hypoventilation Syndrome (Massa et al, 
2019). A significant proportion of unexplained ‘low normal’ SpO2 scores found in population studies 
may have an undiagnosed respiratory condition. 
In addition to population variance, specific factors regarding the protocol used to measure SpO2 may 
affect outcome. Measurements taken whilst lying at rest are statistically significantly different from 
those taken in sitting (Ceylan et al, 2015). Further to this, and age and obesity factors, SpO2 may 
drop over a period of 5-15 minutes at rest (Mehta & Parmar, 2017) and more specifically at rest 
during meditation (Bernardi et al, 2017). Limb temperature, associated with ambient temperature, 
may also have a statistically significant effect (Khan et al, 2015) as can anxiety, the presence of which 
may drop scores a full point (Ardaa et al, 2020). Lastly it is known that Pulse Oximeters have a 
standard error of measurement of +/- 2% when compared to simultaneous arterial blood gas 
measurement, SaO2, (American Thoracic Society, 2018) but pragmatically, from a clinical 
perspective, as there is no way to account for this variance measurements must be taken and acted 
upon at face value. 
Variability of SpO2 over time and repeated measurement is a further issue, with little information 
about this in a non-medical population. One study with a small sample size (n=36) examined SpO2 
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changes over an hour [16] (Bhogal & Mani, 2017) but no reports exist of variability during repeated 
measurement over weeks, as undertaken during Oximetry@Home. 
During a 14 day Oximetry@Home monitoring period with SpO2 taken three times a day, and 
potentially more frequently in an anxious patient, 42 measurements could be taken. Even assuming 
an identical measurement protocol is used on every occasion and a stable clinical condition, it is 
reasonable to suggest there will be some variability in these measurements. With the population 
research using one measurement taken on one occasion showing that 11.5% of individuals may have 
an SpO2 of 95% or below, the probability of finding a low reading on one or more occasions during 
repeated measurement over time when following the Covid 19 recommendations is probably higher 
than 11.5%. 
 
The Impact of SpO2 Variability on the Oximetry@Home pathway 
The algorithm behind Oximetry@Home services recommends that because poor outcomes are 
associated with lower SpO2 scores [17] (Shah et al, 2020); those whose SpO2 drops to 93-94% should 
receive face to face medical assessment and be considered for hospital admission, and those with 
scores of 92% or below should receive urgent secondary medical care. With nationwide 
implementation of Oximetry@Home services, repeated SpO2 measurements taken at home by 
patients will be an important factor in interpreting their clinical condition.   
SpO2 measurement is most frequently performed within a short time of oximeter placement with 
the patient in sitting and not having had a period of rest, walking from a waiting area to a clinical 
area physiologically interrupting rest.. With commissioning of Oximetry@Home services an NHS 
YouTube video (2020) has been released that recommends for home based measurement patients 
lie down for 5 minutes, place the Oximeter, and then take the most stable reading 1 minute after 
placement. This video link has been circulated via the Future NHS Collaboration Platform pages 
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relevant to those setting up Oximetry@Home services but no account appears to have been made 
regarding the potentially lower reading this can give compared to readings taken in sitting. It is 
noteworthy that a further Health Education England NHS video featured in the Daily Mail newspaper 
recommends an entirely different protocol, taking the first reading given in sitting (Daily Mail, 2020).  
In an individual with an unknown usually low score of 95%, a drop of even 1 point due to Covid 19 
infection could result in an Amber rating leading to direct clinical care. What is unclear is whether a 
single point drop in an individual with a pre-disease low score makes direct clinical care an efficient 
use of resources. 
Although the national algorithm also mentions SpO2 drop, with the vast majority of cases not having 
documented pre-disease SpO2 scores this factor becomes impossible to assess until after any initial 
drop caused by the virus that led to SpO2 assessment. It is also unclear clinically from a decision 
making perspective if an individual’s best saturation/perfusion level in sitting should be the baseline 
around which care is organised, or if a reduced saturation/perfusion in lying after rest should be the 
baseline. No nationally agreed policy regarding this appears to exist. 
Discussion 
SpO2% is an eye-catching, publicly available parameter in the evaluation of COVID 19. NHS England 
has acquired 370,000 oximeters for multi-patient use for distribution to services. 
It is probable that the factors described may result in many single point SpO2 measurement changes 
triggering face to face patient reviews either in primary care or emergency departments. Over time 
many thousands of patients may be treated in the community with SpO2 monitoring, potentially 
leading to a significant number of unnecessary face-to-face reviews. When the effect of factors 
affecting SpO2 readings in Covid 19 cases where no pre-disease SpO2 readings are available are 
analysed and placed into the context of population based clinical and home based measurement, 
the potential impact is significant, particularly on those ‘missing millions’ more likely to have 
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borderline SpO2. Additionally Oximetry@Home services are far more likely to select those with 
borderline scores by targeting the over 65’s and those that may have a higher BMI associate with 
comorbidities. The research suggests the ‘low normal’ population will be at least 11.5% of all 
individuals, but due the selection criteria of Oximetry@Home services this percentage appears likely 
to be much greater than this. 
 With the documented factors affecting SpO2 scores at play, those patients with usually lower scores, 
particularly scores of 95%, may potentially move between green and amber ratings on multiple 
occasions. This move could possibly even occur between usual clinical practice measurement in 
sitting at the time of referral to Oximetry@Home, and a patients’ first measure at home if they use 
the lying down for 6 minutes protocol. Patient anxiety upon taking a measurement if they feel 
unwell could also potentially move those with a borderline score to drop below 95% and seek care. 
This could cause multiple unnecessary episodes of face to face care putting additional pressure on 
services already working at, or beyond, capacity.  
Even outside commissioned Oximetry@Home pathways and medical supply of oximeters to 
patients, press coverage of the usefulness of pulse oximeters has been widespread and it is unknown 
what percentage of the population may own a pulse oximeter in response to the Covid 19 Pandemic, 
though with many different suppliers of relatively inexpensive devices and reports of devices selling 
out (CNN, 2020) the number is likely to be in the hundreds of thousands at least. The factors 
described in this article may also affect these individuals, putting further pressure on services. 
 
Recommendations 
1. Due to the device measurement error inherent in pulse oximeters and the narrow 
boundaries of the national oximetry@home algorithm it is recommended that, where 
possible, the mean of three measurements should be used to inform patient and/or clinical 
8 
 
decision making. Patients should be advised that upon taking a reading that might cause 
them to seek medical care, provided their condition is not obviously subjectively 
deteriorating, they should repeat the reading three times over a period of one hour before 
making a decision. 
2. Unification and documentation of SpO2 measurement protocols with a single approved 
national measurement protocol put in place for both patients and clinicians. Pragmatically in 
an out-patient and home setting this protocol should likely be in the sitting position. 
3. Widespread clinical education of relevant NHS staff regarding the potential for low scores 
and the factors that increase the likelihood of those scores to facilitate a more nuanced 
approach to implementation of the national algorithm.  






1. Ardaa KN, SAkaya S, Yetkinb S. (2019) Is there a relationship between oxygen saturation and 
MRI-induced anxiety? A prospective study, Clinical Imaging. 60, 147-152. 
doi.org/10.1016/j.clinimag.2019.12.005 
2. American Thoracic Society Patient Education Series (2018). Pulse Oximetry, Am J Respir Crit 




3. Bakerly ND, Cardwell G. (2016) The ‘missing millions’ Where do we find them? Chronic 
Respiratory Disease. 13, 319-320. doi: 10.1177/1479972316667362 
4. Bernardi F, Bordino M, Bianchi L, Bernardi L. (2017) Acute fall and long-term rise in oxygen 
saturation in response to meditation. Psychophysiology. 54, 1951–1966. 
https://doi.org/10.1111/ psyp.1297 
5. Bhogal AS, Mani AR. (2017) Pattern analysis of oxygen saturation variability in healthy 
individuals: Entropy of pulse oximetry signals carries information about mean oxygen 
saturation. Frontiers in physiology. 2;8:555. https://doi.org/10.3389/fphys.2017.00555 
6. Ceylan B, Khorshid L, Gunes UY, Ayten Zaybak A. (2015) Evaluation of oxygen saturation 
values in different body positions in healthy individuals, Journal of Clinical Nursing. 25, 
1095–1100. doi: 10.1111/jocn.13189 
7. CNN online (2020, April 26th) People are buying pulse oximeters to try and detect 
coronavirus at home. Do you need one? Retrieved from,   
https://edition.cnn.com/2020/04/26/health/pulse-oximeters-coronavirus-wellness-scn-
trnd/index.html 
8. Daily Mail (2020, November 10) Retrieved from,  
https://www.dailymail.co.uk/news/article-8933117/Covid-19-patients-slight-drop-
oxygen-levels-risk-death.html 
9. Dept of Health and Social Care (2020) Demographic data for coronavirus (COVID-19) testing 




10. Enright PL, Sherrill DL. (1998) Reference equations for the six-minute walk in healthy adults. 
Am J Respir Crit Care Med. 158, 1384–1387. 
10 
 
11. Health Education England (2020, November 4) Retrieved from, 
https://www.youtube.com/watch?v=ifnYjD4IKus&feature=youtu.be 
12. Jigar Nayankumar Mehta JN, Parmar LD. (2017) The effect of positional changes on 
oxygenation in patients with head injury in the intensive care unit, Journal of Family 
Medicine and Primary Care. 6, 853-8, DOI: 10.4103/jfmpc.jfmpc_27_17 
13. Kemal Niyazi Ardaa KN, SAkaya S, Yetkinb S. (2020) Is there a relationship between oxygen 
saturation and MRI-induced anxiety? A prospective study, Clinical Imaging. 60, 147-152. 
https://doi.org/10.1016/j.clinimag.2019.12.005  
14. Khan M, Pretty CG, Amies AC, Elliot R, Shaw GM, Chase G. (2015) Investigating the Effects of 
Temperature on Photoplethysmography, IFAC-PapersOnLine. 48, 360-365. 
doi.org/10.1016/j.ifacol.2015.10.166 
15. Masa JF, Pépin JL, Borel JC, Mokhlesi B, Murphy PB, Sánchez-Quiroga MA. (2019) Obesity 
hypoventilation syndrome, European Respiratory Review. 28:180097. DOI: 
10.1183/16000617.0097-2018 
16. NHS England1 (2020). Novel coronavirus (COVID-19) standard operating procedure - COVID 
Oximetry @home. London: NHS England. https://www.england.nhs.uk/coronavirus/wp-
content/uploads/sites/52/2020/06/C0445-remote-monitoring-in-primary-care-revised.pdf     
17. NHS England2 (2020) Pulse oximetry to detect early deterioration of patients with COVID-19 
in primary and community care settings. London: NHS England. 
https://www.england.nhs.uk/coronavirus/wp-content/uploads/sites/52/2020/06/C0445-
remote-monitoring-in-primary-care-revised.pdf 
18. Rodríguez-Molinero A, Narvaiza L,  Ruiz J, Gálvez-Barrón C. (2013) Letters to the Editor, 
Normal Respiratory Rate and Peripheral Blood Oxygen Saturation in the Elderly Population, 
Journal of the American Geriatrics Society. 61, 2238-2240. doi.org/10.1111/jgs.12580 
19. Shah S,  Majmudar K,  Stein A,  Gupta N,  Suppes S, Karamanis M, Capannari J,  Sethi S, Patte 
C. (2020) Novel Use of Home Pulse Oximetry Monitoring in COVID-19 Patients Discharged 
11 
 
From the Emergency Department Identifies Need for Hospitalization, Academic Emergency 
Medicine. 27, 681-692. https://doi.org/10.1111/acem.14053 
20. Torjesen I. (2020) Covid-19: Patients to use pulse oximetry at home to spot deterioration 
BMJ. 371:m4151. doi.org/10.1136/bmj.m4151 
21. Vold ML, Ulf Aasebø U, Wilsgaard T, Melbye H. (2015) Low oxygen saturation and mortality 
in an adult cohort: the Tromsø study, BMC Pulmonary Medicine 15:9. DOI 10.1186/s12890-
015-0003-5 
22. World Health Organisation (2011). Patient Safety. Pulse Oximetry Training Manual. 
https://www.who.int/patientsafety/safesurgery/pulse_oximetry/who_ps_pulse_oxymetry_t
raining_manual_en.pdf 
 
